Yang Liang, Shuhua Yi, Keshu Zhou, Jie Jin, Wenjuan Yu, Jian Ge, Zunmin Zhu, Aijun Liao, Hongling Peng, Fang Zhou, Xiaobing Huang, Guohui Cui, Fei Li, Hongmei Jing, Mingxia Shi, Xiaoqiong Tang, Li Wang, Zhiming Li, Shihua Huang, Liqun Zou, Zengjun Li, Jian-Qing Mi, Yanli Yang, Wei Yang, Jing Cao, Weige Wang, Chen Luo, Renbin Zhao, Lugui Qiu, Wei Xu. "Mesutoclax (ICP-248) monotherapy or combined with orelabrutinib demonstrates encouraging activity and safety in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)." Blood, 2025. doi:10.1182/blood-2025-5677